EP 1452178 A1 20040901 - PERSISTENT FILMY PREPARATION FOR TOPICAL ADMINISTRATION CONTAINING PROSTAGLANDIN DERIVATIVE
Title (en)
PERSISTENT FILMY PREPARATION FOR TOPICAL ADMINISTRATION CONTAINING PROSTAGLANDIN DERIVATIVE
Title (de)
BLEIBEND FILMARTIGE ZUBEREITUNG FÜR DIE TOPISCHE ANWENDUNG, ENTHALTEND EIN PROSTAGLANDIN-DERIVAT
Title (fr)
PREPARATION PELLICULAIRE PERSISTANTE POUR ADMINISTRATION LOCALISEE CONTENANT UN DERIVE DE PROSTAGLANDINE
Publication
Application
Priority
- JP 0207386 W 20020722
- JP 2001345678 A 20011112
Abstract (en)
A sustained release film preparation for local administration to the region of diseases associated with decrease in bone mass, which comprises, as an active ingredient thereof, (11 alpha ,13E,15 alpha )-9-oxo-11,15-dihydroxy-16-(3-methoxymethylphenyl)-17,18,19,20-tetranor-5-thiaprost-13-enoic acid methyl ester having the following formula (I) or a non-toxic salt thereof: <CHEM> and a film comprising a biodegradable polymer. The sustained release film preparation which comprises the compound (I) as an active ingredient of the present invention has activity of accelerating bone formation and is useful for treatment of diseases associated with decrease in bone mass.
IPC 1-7
A61K 31/5575; A61K 9/70; A61P 1/02; A61P 3/14; A61P 19/00; A61P 19/02; A61P 19/08; A61P 19/10; A61P 35/04
IPC 8 full level
A61K 31/5575 (2006.01); A61L 24/00 (2006.01); A61L 24/04 (2006.01); A61L 27/14 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01); A61P 1/02 (2006.01); A61P 3/14 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61P 35/04 (2006.01)
CPC (source: EP KR US)
A61K 31/5575 (2013.01 - EP KR US); A61L 24/0015 (2013.01 - EP US); A61L 24/0042 (2013.01 - EP US); A61L 24/04 (2013.01 - EP US); A61L 27/14 (2013.01 - EP US); A61L 27/54 (2013.01 - EP US); A61L 27/58 (2013.01 - EP US); A61P 1/02 (2017.12 - EP); A61P 3/14 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/08 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 35/04 (2017.12 - EP); A61L 2300/22 (2013.01 - EP US); A61L 2300/412 (2013.01 - EP US); A61L 2300/604 (2013.01 - EP US)
Citation (search report)
See references of WO 03041717A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
EP 1452178 A1 20040901; CA 2467061 A1 20030522; JP WO2003041717 A1 20050303; KR 20050012221 A 20050131; US 2004258730 A1 20041223; WO 03041717 A1 20030522
DOCDB simple family (application)
EP 02747708 A 20020722; CA 2467061 A 20020722; JP 0207386 W 20020722; JP 2003543604 A 20020722; KR 20047006946 A 20020722; US 49516004 A 20040511